CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- 8-K Event Material agreement · Results of operations · New debt or obligation · Executive or director change · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market buy EVP and COO bought 200 shares at $1.18 ($236)
- 4 Open-market buy EVP and COO bought 200 shares at $1.21 ($242)
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 424B4 Offering Prospectus
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 4 Open-market buy EVP and COO bought 353 shares at $1.40 ($494)
- 4 Open-market buy Director bought 27,000 shares at $1.79 ($48,330)
- 4 Open-market buy Corporate Controller bought 1,900 shares at $1.39 ($2,641)
- 4 Open-market buy Corporate Controller bought 12,000 shares at $1.46 ($17,494)
Page 20 of 25 · 494 filings